Clinical Trial Update: Optimal Stimulation Parameters to Disrupt Epileptiform Activity [NA]

View source ↗

Summary

A Massachusetts General Hospital-sponsored clinical trial aims to identify optimal stimulation parameters to disrupt epileptiform activity in patients with refr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Refractory Epilepsy | NA | Status: RECRUITING